Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Lipworth

Showing results (1-10 of 189) with videos related to

Pageof 19
Sort By:
Thorax|July 4, 2013
Systemic safety of fluticasone furoate/vilanterol combinationBrian Lipworth
The Journal of Allergy and Clinical Immunology|May 29, 2016
Improvements with sublingual house dust mite immunotherapy in allergic rhinitisBrian Lipworth
Thorax|June 21, 2015
Triple inhaler therapy for COPDBrian Lipworth
The Lancet. Respiratory Medicine|May 14, 2015
Tiotropium in asthmaBrian Lipworth
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 31, 2013
Author responseBrian Lipworth
American Journal of Respiratory and Critical Care Medicine|December 17, 2013
β-Adrenoceptor genotype and bronchoprotective subsensitivity with long-acting β-agonists in asthmaBrian Lipworth
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 29, 2013
Targeting the small airways asthma phenotype: if we can reach it, should we treat it?Brian Lipworth
The Journal of Allergy and Clinical Immunology|May 12, 2015
Nasal endoscopy to characterize sinonasal diseaseBrian Lipworth
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 30, 2006
Phosphodiesterase type 4 inhibitors for asthma: a real breakthrough or just expensive theophylline?Brian Lipworth
The Journal of Allergy and Clinical Immunology|September 10, 2013
Uncorrected nitric oxide levels in mild asthmatics produce flawed interpretationBrian Lipworth
Pageof 19

Showing results (1-10 of 189) with videos related to

Sort By:
Pageof 19
Thorax|July 4, 2013
Systemic safety of fluticasone furoate/vilanterol combinationBrian Lipworth
The Journal of Allergy and Clinical Immunology|May 29, 2016
Improvements with sublingual house dust mite immunotherapy in allergic rhinitisBrian Lipworth
Thorax|June 21, 2015
Triple inhaler therapy for COPDBrian Lipworth
The Lancet. Respiratory Medicine|May 14, 2015
Tiotropium in asthmaBrian Lipworth
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 31, 2013
Author responseBrian Lipworth
American Journal of Respiratory and Critical Care Medicine|December 17, 2013
β-Adrenoceptor genotype and bronchoprotective subsensitivity with long-acting β-agonists in asthmaBrian Lipworth
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 29, 2013
Targeting the small airways asthma phenotype: if we can reach it, should we treat it?Brian Lipworth
The Journal of Allergy and Clinical Immunology|May 12, 2015
Nasal endoscopy to characterize sinonasal diseaseBrian Lipworth
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 30, 2006
Phosphodiesterase type 4 inhibitors for asthma: a real breakthrough or just expensive theophylline?Brian Lipworth
The Journal of Allergy and Clinical Immunology|September 10, 2013
Uncorrected nitric oxide levels in mild asthmatics produce flawed interpretationBrian Lipworth
Pageof 19